MindWalk Holdings (HYFT) Income from Discontinued Operations (2024 - 2026)
MindWalk Holdings' (HYFT) quarterly Income from Discontinued Operations came in at $930120.2 in Q2 2026, up 3.81% year-over-year from $895979.1 in Q2 2025, and up 5276.08% quarter-over-quarter from $17301.1 in Q4 2025.
Analysis
MindWalk Holdings (HYFT) Income from Discontinued Operations (2024 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Income from Discontinued Operations for 3 consecutive years, with $930120.2 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Discontinued Operations rose 3.81% year-over-year to $930120.2 in Q2 2026; TTM through Apr 2026 was $1.8 million, a 98.88% decrease from a year earlier, with the FY2026 full-year figure at $10.1 million, down 53.42% from the prior year.
- Income from Discontinued Operations was $930120.2 for Q2 2026 at MindWalk Holdings, up from $17301.1 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $155.6 million in Q3 2024 and troughed at $17301.1 in Q4 2025.
- A 3-year average of $22.8 million and a median of $821669.6 in 2025 frame the typical range for Income from Discontinued Operations.
- Across the five-year window, Income from Discontinued Operations tumbled 99.47% in 2025 and gained 3.81% in 2026, its largest moves.
- Over 3 years, Income from Discontinued Operations stood at $727895.0 in 2024, then slumped by 97.62% to $17301.1 in 2025, then surged by 5276.08% to $930120.2 in 2026.
- The last three Income from Discontinued Operations figures came in at $930120.2 (Q2 2026), $17301.1 (Q4 2025), and $821669.6 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 10.61 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 930,120.18 |
| Oct 31, 2025 | 17,301.10 |
| Jul 31, 2025 | 821,669.64 |
| Apr 30, 2025 | 895,979.08 |
| Jan 31, 2025 | 303,607.97 |
| Oct 31, 2024 | 727,894.97 |
| Jul 31, 2024 | 155.56 Mn |